Press Releases

The 60th Annual Meeting of the European Association for the Study of Diabetes (EASD) was held in Madrid, Spain, from 9 to 13 September 2024. Hansoh Ph...

From September 6th to 9th, the 41st China Pharmaceutical Industry Information Annual Conference was held in Chengdu, where the highly anticipated rank...

A real-world study of GLP-1 receptor agonists (GLP-1RAs) for treating patients with diabetic kidney disease (DKD) was recently published in the intern...

Results from a randomized clinical trial on Hansoh Pharma's Fulaimei (PEG loxenatide injection) for the treatment of patients with diabetic kidney dis...

The 2024 ADA Meeting was held in Orlando, USA, from June 21st to 24th, this year. Hansoh Pharma's HS-20094 (a novel Dual GIP and GLP-1 Receptor Agonis...

The 2024 ASCO Annual Meeting was held in Chicago from 31st May to 4th June local time. As the world's most prominent, advanced, and influential clinic...

Recently, the Chinese Journal of Nephrologyreleased the “Chinese Expert Consensus on Long-Acting Erythropoiesis-Stimulating Agents in the Treatment of...

On April 25, 2024, Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK), China's leading innovation-driven pharmaceutical company, and Qyun...